Punjab Chemicals & Crop Protection Limited — PPTs, 29-07-2025: Investor Presentation

Here's a summary of the attached investor presentation:

**Financial Highlights:**

Q1 FY26 revenue hit ₹320 Cr (+31.9% YoY), EBITDA ₹34 Cr (+24.5% YoY, 10.8% margin), and PAT ₹21 Cr (+52.8% YoY, 6.5% margin). Gross margins were 33.1%. FY25 showed healthy 16% ROCE and 11% ROE.

**Strategic Initiatives & Growth Drivers:**

Four new products target commercialization in 2-3 quarters. R&D facilities are expanding with investments adding new chemistries. New manufacturing block and capacity debottlenecking are underway, due in six quarters.

**Business Developments:**

Three MOUs were signed for export-oriented products. A new agrochemical herbicide was commercialized domestically in Q1.

**Market Position & Competitive Advantage:**

PCCPL operates in Agrochemicals, Pharma, Industrial Chemicals, with strong manufacturing (2000 KL reactor, ZLD) and R&D (doubling FY26). It's positioned as a preferred CRAMS provider, benefiting from global supply chain shifts.

**Investor Implications:**

Strong Q1 FY26 results, promising product pipeline, and significant R&D/capacity investments signal positive growth potential. Strategic partnerships and high-value segment focus reinforce a favorable long-term outlook.